Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles.

ABSTRACT: Extensive and multi-dimensional data sets generated from recent cancer omics profiling projects have presented new challenges and opportunities for unraveling the complexity of cancer genome landscapes. In particular, distinguishing the unique complement of genes that drive tumorigenesis in each patient from a sea of passenger mutations is necessary for translating the full benefit of cancer genome sequencing into the clinic. We address this need by presenting a data integration framework (OncoIMPACT) to nominate patient-specific driver genes based on their phenotypic impact. Extensive in silico and in vitro validation helped establish OncoIMPACT's robustness, improved precision over competing approaches and verifiable patient and cell line specific predictions (2/2 and 6/7 true positives

SUBMITTER: Bertrand D 

PROVIDER: S-EPMC4402507 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature